<- Go Home

Daewoong Pharmaceutical Co., Ltd

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Market Cap

KRW 1.7T

Volume

40.5K

Cash and Equivalents

KRW 94.6B

EBITDA

KRW 183.9B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

KRW 724.5B

Profit Margin

51.15%

52 Week High

KRW 164.4K

52 Week Low

KRW 100.1K

Dividend

N/A

Price / Book Value

2.02

Price / Earnings

15.97

Price / Tangible Book Value

3.39

Enterprise Value

KRW 2.3T

Enterprise Value / EBITDA

10.19

Operating Income

KRW 136.5B

Return on Equity

10.75%

Return on Assets

4.70

Cash and Short Term Investments

KRW 107.5B

Debt

KRW 618.2B

Equity

KRW 951.4B

Revenue

KRW 1.4T

Unlevered FCF

-KRW 165.4B

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches